197 related articles for article (PubMed ID: 18326158)
1. First-line therapies for lowering triglyceride levels.
Raghavan VA
Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
[No Abstract] [Full Text] [Related]
2. Drugs for lipids.
Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
[No Abstract] [Full Text] [Related]
3. Clinical practice. Hypertriglyceridemia.
Brunzell JD
N Engl J Med; 2007 Sep; 357(10):1009-17. PubMed ID: 17804845
[No Abstract] [Full Text] [Related]
4. Treating hypertriglyceridemia.
Röggla G; Fasan M; Kapiotis S
CMAJ; 2007 Sep; 177(6):603; author reply 604-5. PubMed ID: 17846444
[No Abstract] [Full Text] [Related]
5. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
6. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
7. Treating hypertriglyceridemia.
Yavasoglu I; Kadikoylu G; Bolaman Z
CMAJ; 2007 Sep; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
[No Abstract] [Full Text] [Related]
8. On the road to better dyslipidemia outcomes.
Hughes S
Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
[No Abstract] [Full Text] [Related]
9. Drugs for hypertriglyceridemia.
Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
[No Abstract] [Full Text] [Related]
10. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
11. Utility of currently available modes of therapy in reaching lipid goals.
Spratt KA; Denke MA
J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
[TBL] [Abstract][Full Text] [Related]
12. Demystifying triglycerides: a practical approach for the clinician.
Dunbar RL; Rader DJ
Cleve Clin J Med; 2005 Aug; 72(8):661-6, 670-2, 674-5 passim. PubMed ID: 16122052
[TBL] [Abstract][Full Text] [Related]
13. Choice of lipid-regulating drugs.
Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
[No Abstract] [Full Text] [Related]
14. Hypertriglyceridemia and cardiovascular disease management.
Codario RA
J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
[No Abstract] [Full Text] [Related]
15. Statin-fibrate combination therapy.
Feeman WE
Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
[No Abstract] [Full Text] [Related]
16. Diabetic dyslipidemia: a practical guide to therapy.
Tovar JM; Bazaldua OV; Loffredo A
J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
[TBL] [Abstract][Full Text] [Related]
17. Current drug treatments for lipid management.
Stone NJ
Manag Care; 2002 Sep; 11(9 Suppl):4-9. PubMed ID: 12369341
[No Abstract] [Full Text] [Related]
18. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review.
Plaisance EP; Grandjean PW; Mahurin AJ
Phys Sportsmed; 2009 Apr; 37(1):11-9. PubMed ID: 20048483
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidaemia in diabetes.
Patel J
Clin Evid; 2006 Jun; (15):555-75. PubMed ID: 16973026
[No Abstract] [Full Text] [Related]
20. Treating hypertriglyceridemia.
Holub BJ
CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
[No Abstract] [Full Text] [Related]
[Next] [New Search]